US 9585874
Nuclear transport modulators and uses thereof
granted A61KA61K31/4196A61K31/454
Quick answer
US patent 9585874 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Karyopharm Therapeutics Inc.
- Grant date
- Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4196, A61K31/454, A61K31/497, A61K31/5377